Home › Funds › Eversept Partners, LP › LQDA

Eversept Partners, LP position in LQDA

LIQUIDIA CORPORATION · Health Care

Eversept Partners, LP reported holding 641,986 shares of LQDA (LIQUIDIA CORPORATION) in its Q3 2026 13F filing — a position valued at US$19.4M, representing 1.04% of its reported portfolio and ranking #27 among its reported holdings. Eversept Partners, LP has disclosed LQDA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)641.99K sh
Reported value held$19.43M
Portfolio Weight1.04%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Eversept Partners, LP's LQDA position evolved

Eversept Partners, LP first disclosed a stake in LQDA in Q3 2023 at 1,395,454 shares (US$8.8M). The position peaked in Q2 2026 at 428,652 shares, worth US$34.2M. Across 13 filings, Eversept Partners, LP increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 641,986 shares valued at US$19.4M — an increase of 213,334 shares quarter over quarter.. Notable position changes include a 314% increase in Q4 2024 (shares rose 25% over the following quarter), a 74% trim in Q1 2025 (shares fell 16% over the following quarter), a 138% increase in Q2 2025 (shares rose 83% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.40M $8.85M New
Q4 2023 688.93K $8.29M Reduce
Q1 2024 396.19K $5.84M Reduce
Q2 2024 373.55K $4.48M Reduce
Q3 2024 137.95K $1.38M Reduce
Q4 2024 571.30K $6.72M Add
Q1 2025 150.48K $2.22M Reduce
Q2 2025 358.83K $4.47M Add
Q3 2025 486.02K $11.05M Add
Q4 2025 509.44K $17.57M Add
Q1 2026 677.39K $25.56M Add
Q2 2026 428.65K $34.18M Reduce
Q3 2026 641.99K $19.43M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LQDA and 13F data

LQDA (LIQUIDIA CORPORATION) is a Health Care company. 49 other funds we track also report a position in LQDA — the largest reported positions include Farallon Capital Management (US$666.9M), Caligan Partners LP (US$647.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$269.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LQDA

All LQDA fund holders →

FAQ

How long has Eversept Partners, LP held LQDA?

Eversept Partners, LP has disclosed LQDA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Eversept Partners, LP's current position in LQDA?

As of Q3 2026, Eversept Partners, LP holds 641.99K shares of LQDA (LIQUIDIA CORPORATION), valued at $19.43M, representing 1.04% of its reported portfolio and ranking #27.

Has Eversept Partners, LP been buying or selling LQDA?

In the latest 13F filing (Q3 2026), Eversept Partners, LP increased its position in LQDA. The position peaked in Q2 2026 at 428.65K shares.

Which other funds hold LQDA?

Other major institutional holders of LQDA include Farallon Capital Management, Caligan Partners LP, FARALLON CAPITAL MANAGEMENT, L.L.C., among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.